Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04182568 | Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer | unknown | Phase 4 | 100 | Xijing HospitalOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT03583944 | A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer | completed | Phase 4 | 200 | Eisai Inc.INDUSTRY | 1 | Nov 27, 2019 | clinicaltrials |
| NCT02445586 | Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer | completed | Phase 4 | 52 | Hoffmann-La RocheINDUSTRY | 1 | Oct 29, 2019 | clinicaltrials |
| NCT04116021 | The Analgesic Efficacy of the Pectoral Nerves Block Versus Local Anesthetic Infiltration After Mastectomy(PECS) | unknown | Phase 4 | 50 | Hôpital du ValaisOTHER | 0 | Oct 4, 2019 | clinicaltrials |
| NCT02344940 | Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer(TTOS) | completed | Phase 4 | 104 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT02819921 | Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen | terminated | Phase 4 | 59 | Seoul National University HospitalOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT03456661 | Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block | terminated | Phase 4 | 40 | University Hospital, AntwerpOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT00756717 | Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer(MK-0752) | completed | Phase 4 | 22 | Loyola UniversityOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT03123770 | Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients(ESNDBCP) | unknown | Phase 4 | 384 | Zhejiang UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT02590315 | Tomosynthesis Versus Digital Mammography in a Population-based Screening Program(ProteusDonna) | unknown | Phase 4 | 92,000 | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03799679 | Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer | unknown | Phase 4 | 60 | Fudan UniversityOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT03799757 | Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain | completed | Phase 4 | 168 | Alexandria UniversityOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT03238703 | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer | withdrawn | Phase 4 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 27, 2018 | clinicaltrials |
| NCT01948960 | Influence of Exceptional Patient Characteristics on Everolimus Exposure(INPRES) | completed | Phase 4 | 56 | Radboud University Medical CenterOTHER | 1 | Dec 7, 2018 | clinicaltrials |
| NCT03676114 | Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery | unknown | Phase 4 | 100 | Han YuanOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT00812864 | Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)(capagec) | completed | Phase 4 | 20 | University Hospital, LimogesOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT03199560 | Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy | unknown | Phase 4 | 86 | Memorial Health University Medical CenterOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT01537029 | Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide | completed | Phase 4 | 15 | Texas Tech University Health Sciences CenterOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03591549 | Fulvestrant in Metastatic Breast Cancer | unknown | Phase 4 | 30 | Assiut UniversityOTHER | 0 | Jul 23, 2018 | clinicaltrials |
| NCT02372305 | Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery | withdrawn | Phase 4 | 0 | University of ArkansasOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT00772824 | Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients | completed | Phase 4 | 23 | Banaras Hindu UniversityOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT03586154 | Combined Intra-articular Shoulder Injection and Stellate Ganglion Block in Chronic Post-mastectomy Shoulder Pain | completed | Phase 4 | 70 | Mansoura UniversityOTHER | 1 | Jul 16, 2018 | clinicaltrials |
| NCT01501487 | MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I(MINT) | completed | Phase 4 | 226 | AgendiaINDUSTRY | 1 | Jun 28, 2018 | clinicaltrials |
| NCT01094184 | A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer(BATMAN) | completed | Phase 4 | 49 | Hoffmann-La RocheINDUSTRY | 1 | Mar 22, 2018 | clinicaltrials |
| NCT03465202 | Association of Capecitabine Pharmacokinetics and Toxicity With Aging | unknown | Phase 4 | 100 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 0 | Mar 14, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT00882089 | Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients | completed | Phase 4 | 13 | Cancer Center of IrvineOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT00882596 | Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients | completed | Phase 4 | 30 | Cancer Center of IrvineOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT02173262 | REaCT Integrated Consent Model to Compare Two Standard of Care Regimens(OTT14-03) | completed | Phase 4 | 142 | Ottawa Hospital Research InstituteOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00485953 | Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy(REBBeCA II) | completed | Phase 4 | 109 | Susan L. GreenspanOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT00754767 | L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer | terminated | Phase 4 | 2 | HealthPartners InstituteOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT01766102 | Intra-operative Digital vs. Standard Mammography | completed | Phase 4 | 72 | Massachusetts General HospitalOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT01907880 | The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer(ER11-03) | completed | Phase 4 | 74 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT00375752 | Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer(FEMZONE) | terminated | Phase 4 | 168 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00604968 | Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059) | terminated | Phase 4 | 25 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 7, 2017 | clinicaltrials |
| NCT00872859 | The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial | completed | Phase 4 | 128 | University of UtahOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT01781299 | Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU | completed | Phase 4 | 9 | University of PittsburghOTHER | 1 | May 12, 2017 | clinicaltrials |
| NCT00176046 | Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study | completed | Phase 4 | 114 | Heidelberg UniversityOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00092183 | An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) | completed | Phase 4 | 866 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 5, 2017 | clinicaltrials |
| NCT00237133 | Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women(PREDICT) | completed | Phase 4 | 112 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00372476 | Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer(INV181) | completed | Phase 4 | 33 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00087620 | A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer | terminated | Phase 4 | — | Hoffmann-La RocheINDUSTRY | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01301729 | A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment | completed | Phase 4 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Dec 29, 2016 | clinicaltrials |
| NCT02982148 | Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients | unknown | Phase 4 | 352 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00774241 | PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01156961 | A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Dec 2, 2019source: clinicaltrials